5-Amino-4-imidazolecarboxamide 50 mg | 100.00%
TargetMol
5-Amino-4-imidazolecarboxamide
Search Results
SB-431542 100 mg | 99.87%
TargetMol
SB-431542(SB 431542) is a potent and selective inhibitor of ALK5 (IC50: 94 nM) and is also an inhibitor of ALK4 (IC50: 140 nM) and ALK7.
More Information Supplier PageSB-431542
SB-431542 10 mg | 99.87%
TargetMol
SB-431542(SB 431542) is a potent and selective inhibitor of ALK5 (IC50: 94 nM) and is also an inhibitor of ALK4 (IC50: 140 nM) and ALK7.
More Information Supplier PageSB-431542
7ACC2 10 mg | 100.00%
TargetMol
7ACC2 is a new potent MCT inhibitor with IC50 of 11 nM for [14C]-lactate influx; new antitumor treatment targeting lactate transport in Y cells.
More Information Supplier Page7ACC2
7ACC2 2 mg | 100.00%
TargetMol
7ACC2 is a new potent MCT inhibitor with IC50 of 11 nM for [14C]-lactate influx; new antitumor treatment targeting lactate transport in Y cells.
More Information Supplier Page7ACC2
7ACC2 5 mg | 100.00%
TargetMol
7ACC2 is a new potent MCT inhibitor with IC50 of 11 nM for [14C]-lactate influx; new antitumor treatment targeting lactate transport in Y cells.
More Information Supplier Page7ACC2
Plerixafor octahydrochloride 100 mg | Purity Not Available
TargetMol
AMD 3100 octahydrochloride blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.
More Information Supplier PagePlerixafor octahydrochloride
Plerixafor octahydrochloride 10 mg | Purity Not Available
TargetMol
AMD 3100 octahydrochloride blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.
More Information Supplier PagePlerixafor octahydrochloride
Plerixafor octahydrochloride 50 mg | Purity Not Available
TargetMol
AMD 3100 octahydrochloride blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.
More Information Supplier PagePlerixafor octahydrochloride
MBX-2982 10 mg | 98.83%
TargetMol
MBX-2982 is a selective, orally-available GPR119 agonist, used for the treatment of diabetes.
More Information Supplier PageMBX-2982
